| pubmed-article:21145871 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21145871 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:21145871 | lifeskim:mentions | umls-concept:C2239176 | lld:lifeskim |
| pubmed-article:21145871 | lifeskim:mentions | umls-concept:C1176020 | lld:lifeskim |
| pubmed-article:21145871 | lifeskim:mentions | umls-concept:C1705165 | lld:lifeskim |
| pubmed-article:21145871 | lifeskim:mentions | umls-concept:C0683598 | lld:lifeskim |
| pubmed-article:21145871 | lifeskim:mentions | umls-concept:C0439661 | lld:lifeskim |
| pubmed-article:21145871 | lifeskim:mentions | umls-concept:C2700061 | lld:lifeskim |
| pubmed-article:21145871 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:21145871 | pubmed:dateCreated | 2011-4-18 | lld:pubmed |
| pubmed-article:21145871 | pubmed:abstractText | Based on the success of sorafenib, several anti-angiogenic therapies are currently evaluated in advanced hepatocellular carcinomas. Few biological data are currently available from patients that may help understanding mechanisms of acquired resistance to these drugs. Herein, we report translational data from a post-treatment surgical specimen in a patient who experienced acquired resistance to sunitinib. | lld:pubmed |
| pubmed-article:21145871 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21145871 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21145871 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21145871 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21145871 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21145871 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21145871 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21145871 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21145871 | pubmed:month | May | lld:pubmed |
| pubmed-article:21145871 | pubmed:issn | 0168-8278 | lld:pubmed |
| pubmed-article:21145871 | pubmed:author | pubmed-author:BiecheIvanI | lld:pubmed |
| pubmed-article:21145871 | pubmed:author | pubmed-author:ParadisValéri... | lld:pubmed |
| pubmed-article:21145871 | pubmed:author | pubmed-author:FaivreSandrin... | lld:pubmed |
| pubmed-article:21145871 | pubmed:author | pubmed-author:RaymondEricE | lld:pubmed |
| pubmed-article:21145871 | pubmed:author | pubmed-author:ZappaMagalyM | lld:pubmed |
| pubmed-article:21145871 | pubmed:author | pubmed-author:DokmakSafiS | lld:pubmed |
| pubmed-article:21145871 | pubmed:author | pubmed-author:BouattourMoha... | lld:pubmed |
| pubmed-article:21145871 | pubmed:author | pubmed-author:MarijonHélène... | lld:pubmed |
| pubmed-article:21145871 | pubmed:copyrightInfo | Copyright © 2011. Published by Elsevier B.V. | lld:pubmed |
| pubmed-article:21145871 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:21145871 | pubmed:volume | 54 | lld:pubmed |
| pubmed-article:21145871 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21145871 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21145871 | pubmed:pagination | 1073-8 | lld:pubmed |
| pubmed-article:21145871 | pubmed:meshHeading | pubmed-meshheading:21145871... | lld:pubmed |
| pubmed-article:21145871 | pubmed:meshHeading | pubmed-meshheading:21145871... | lld:pubmed |
| pubmed-article:21145871 | pubmed:meshHeading | pubmed-meshheading:21145871... | lld:pubmed |
| pubmed-article:21145871 | pubmed:meshHeading | pubmed-meshheading:21145871... | lld:pubmed |
| pubmed-article:21145871 | pubmed:meshHeading | pubmed-meshheading:21145871... | lld:pubmed |
| pubmed-article:21145871 | pubmed:meshHeading | pubmed-meshheading:21145871... | lld:pubmed |
| pubmed-article:21145871 | pubmed:meshHeading | pubmed-meshheading:21145871... | lld:pubmed |
| pubmed-article:21145871 | pubmed:meshHeading | pubmed-meshheading:21145871... | lld:pubmed |
| pubmed-article:21145871 | pubmed:meshHeading | pubmed-meshheading:21145871... | lld:pubmed |
| pubmed-article:21145871 | pubmed:meshHeading | pubmed-meshheading:21145871... | lld:pubmed |
| pubmed-article:21145871 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21145871 | pubmed:articleTitle | Epithelial-to-mesenchymal transition and acquired resistance to sunitinib in a patient with hepatocellular carcinoma. | lld:pubmed |
| pubmed-article:21145871 | pubmed:affiliation | Department of Medical Oncology (APHP), Beaujon University Hospital, Paris 7 Diderot, Clichy, France. | lld:pubmed |
| pubmed-article:21145871 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21145871 | pubmed:publicationType | Case Reports | lld:pubmed |
| pubmed-article:21145871 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
